Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7338)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2018 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Deibert P, Lazaro A, Stankovic Z, Schaffner D, Rössle M, Kreisel W. Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up. World J Gastroenterol 2018; 24(3): 438-444 [PMID: 29391766 DOI: 10.3748/wjg.v24.i3.438] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i3/438.htm |
| Number | Citing Articles |
| 1 |
Wolfgang Kreisel, Denise Schaffner, Adhara Lazaro, Jonel Trebicka, Irmgard Merfort, Annette Schmitt-Graeff, Peter Deibert. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension. International Journal of Molecular Sciences 2020; 21(17): 6223 doi: 10.3390/ijms21176223
|
| 2 |
Wolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, Markus Grosse Perdekamp, Annette Schmitt-Graeff, Peter Deibert. Cyclic GMP in Liver Cirrhosis—Role in Pathophysiology of Portal Hypertension and Therapeutic Implications. International Journal of Molecular Sciences 2021; 22(19): 10372 doi: 10.3390/ijms221910372
|
| 3 |
Mahmoud S. Sabra, Ahmed A. Mohammed, Khaled M. Ahmed Hassanein, Ahmed A. N. Ahmed, Dalia Hassan, Ebtsam S. Abdel-lah. Novel drug therapy of acute hepatic failure induced in rats by a combination of tadalafil and Lepidium sativum. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04406-4
|
| 4 |
Frank E. Uschner, Kathleen Glückert, Rafael Paternostro, Thorsten Gnad, Robert Schierwagen, Mattias Mandorfer, Fernando Magdaleno, Cristina Ortiz, Katharina Schwarzkopf, Patrick S. Kamath, Carlo Alessandria, Christoph Boesecke, Alexander Pfeifer, Thomas Reiberger, Wolfgang Kreisel, Tilman Sauerbruch, Arnulf Ferlitsch, Jonel Trebicka, Sabine Klein. Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction. Liver International 2020; 40(9): 2228 doi: 10.1111/liv.14586
|
| 5 |
Rui-Zhao Qi, Zhi-Wei Li, Zheng-Yao Chang, Wei-Hua Chang, Wen-Lei Zhao, Chuan Pang, Ying Zhang, Xing-Long Hu, Feng Liang. Clinical efficacy of total laparoscopic splenectomy for portal hypertension and its influence on hepatic hemodynamics and liver function. World Journal of Gastrointestinal Surgery 2023; 15(8): 1684-1692 doi: 10.4240/wjgs.v15.i8.1684
Abstract(165) |
Core Tip(163) |
Full Article(HTML)(557)
|
Full Article with Cover (PDF)-1502K(27)
|
Full Article (Word)-309K(25)
|
Audio-1498K(3)
|
Peer-Review Report-247K(22)
|
Answering Reviewers-41K(21)
|
Full Article (PDF)-945K(67)
|
Full Article (XML)-80K(25)
|
Times Cited (0)
|
Total Visits (2021)
|
Open
|
| 6 |
Rakesh Kumar Jagdish. Sexual dysfunctions and their treatment in liver diseases. World Journal of Hepatology 2022; 14(8): 1530-1540 doi: 10.4254/wjh.v14.i8.1530
|
| 7 |
Sergi Guixé-Muntet, Chang-Peng Zhu, Wei-Fen Xie, Jordi Gracia-Sancho. Novel therapeutics for portal hypertension and fibrosis in chronic liver disease. Pharmacology & Therapeutics 2020; 215: 107626 doi: 10.1016/j.pharmthera.2020.107626
|
| 8 |
Ji-Yao Sheng, Zi-Fan Meng, Qiao Li, Yong-Sheng Yang. Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension. Hepatobiliary & Pancreatic Diseases International 2024; 23(1): 4 doi: 10.1016/j.hbpd.2023.08.003
|
| 9 |
Marina Vilaseca, Sergi Guixé-Muntet, Anabel Fernández-Iglesias, Jordi Gracia-Sancho. Advances in therapeutic options for portal hypertension. Therapeutic Advances in Gastroenterology 2018; 11: 175628481881129 doi: 10.1177/1756284818811294
|
| 10 |
Hui Li. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma. Digestive and Liver Disease 2022; 54(5): 598 doi: 10.1016/j.dld.2021.07.006
|
| 11 |
Felix Abayomi Dada, Sunday Idowu Oyeleye, Stephen Adeniyi Adefegha, Ganiyu Oboh.
Extracts from Almond (
Terminalia catappa
) leaf and stem bark mitigate the activities of crucial enzymes and oxidative stress associated with hypertension in cyclosporine A‐stressed rats
. Journal of Food Biochemistry 2021; 45(3) doi: 10.1111/jfbc.13435
|
| 12 |
Moein Ala, Razieh Mohammad Jafari, Ahmad Reza Dehpour. Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications. Fundamental & Clinical Pharmacology 2021; 35(2): 235 doi: 10.1111/fcp.12633
|
| 13 |
Rakesh Kumar Jagdish, Ahmed Kamaal, Saggere Muralikrishna Shasthry, Jaya Benjamin, Rakhi Maiwall, Ankur Jindal, Ashok Choudhary, Vijayaraghavan Rajan, Vinod Arora, Ankit Bhardwaj, Guresh Kumar, Manoj Kumar, Shiv K. Sarin. Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial. Hepatology International 2023; 17(2): 434 doi: 10.1007/s12072-021-10264-w
|
| 14 |
Sasan Sakiani, Theo Heller, Christopher Koh. Current and investigational drugs in early clinical development for portal hypertension. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.974182
|